Since it is known, that Seminoma can be Epstein-Barr virus positive, the regulation mechanism between the tumor development and the EBV positivity is still unkown. EBV is involved in several different cancers and is the predominant activator of the miR-199a-3p. MiRs are small non coding RNA sequences which regulate the expression of proteins. The miR-199a-3p binds to the 3'UTR of Endothelin-1 (ET-1) a vasoconstrictive protein. One of the two ET-1 receptors (ETAR and ETBR), namely the ETBR receptor is in seminoma with non-metastasizing potential downregulated indicating that an imbalance of the ET-1 cycle is present. ET-1 is an important activator for the miR-498 a miR which is necessary for the production of a truncated version of Vimentin, called Vim3. Vim3 is involved in several different processes and is upregulated in tumors with increasing metastasizing potential. This work predominantly focused on the EBV induced signaling and if this signaling process influences the Vim3 expression in seminoma.
INTRODUCTION AND OBJECTIVES:
Since it is known, that Seminoma can be Epstein-Barr virus positive, the regulation mechanism between the tumor development and the EBV positivity is still unkown. EBV is involved in several different cancers and is the predominant activator of the miR-199a-3p. MiRs are small non coding RNA sequences which regulate the expression of proteins. The miR-199a-3p binds to the 3'UTR of Endothelin-1 (ET-1) a vasoconstrictive protein. One of the two ET-1 receptors (ETAR and ETBR), namely the ETBR receptor is in seminoma with non-metastasizing potential downregulated indicating that an imbalance of the ET-1 cycle is present. ET-1 is an important activator for the miR-498 a miR which is necessary for the production of a truncated version of Vimentin, called Vim3. Vim3 is involved in several different processes and is upregulated in tumors with increasing metastasizing potential. This work predominantly focused on the EBV induced signaling and if this signaling process influences the Vim3 expression in seminoma.
METHODS: Patient serum and paraffinized tissue samples from seminoma patients and control patients were accessed through our biobank (n[40). The disease group consists of patients with pT1-pT2 diagnosed seminoma with and without metastasis. On paraffinized tissue samples from patients with and without Seminoma as well as a high control (patient with Lymphoma) an IHC staining of the presence of EBV was performed. Furthermore, miR was isolated and miR-199a-3p qRT-PCR was established. Via ELISA the presences of ET-1 and Vim3 was analyzed in patient serum with and without seminoma samples (n[38) .
RESULTS: IHC staining shows that 62.5% of our seminoma samples were positive for EBV and 32.5% were negative. No differences between the tumor staging and the metastasising behaviour were detectable. The miR results indicate that the miR-199a-3p was significantly upregulated in all EBVþ samples. Vim3 staining was negative in all EBVþ positive tumors. ELISAs from patient serum samples with and without seminoma indicate that ET-1 and Vim3 was significantly downregulated in seminoma samples.
CONCLUSIONS: Here we present for the first time, the correlation between EBV infection and the downregulating mechanism of Vim3. EBV is responsible for the upregulation of miR-199a-3p which binds to the 3'UTR of the ET-1 mRNA and resulting in significant downregulation of ET-1. ET-1 is the main inducer of Vim3, which was as well downregulated in EBVþ seminoma. Further studies needed to show whether patients with EBVþ seminoma have a better prognosis, since the Vim3 metastasizing marker is downregulated.
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INTRODUCTION AND OBJECTIVES:
The main predictor of survival in penile squamous cell carcinoma (PSCC) remains the presence and the extent of regional lymph node involvement. Despite being the standard of care for inguinal clinical node positive or inguinal clinical node negative with intermediate and high risk in PSCC, the radical inguinal lymph node dissection (ILND) is associated with significant morbidity and it may be an overtreatment in many patients. There is growing evidence to support the association of systemic inflammation in cancer development and progression. Therefore, we aimed to evaluate whether systemic inflammatory markers in peripheral blood before ILND can predict the presence of positive pathological nodes (pNþ).
METHODS: We retrospectively reviewed data from 230 patients with penile cancer followed between 2009 and 2018 in a single center, to identify 79 patients who were submitted to ILND for non-metastatic PSCC. We evaluated neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and platelet to lymphocyte ratio (PLR) obtained preoperatively. The cut-off point of NLR ! 3.0 was chosen following positive results found in previous studies in penile cancer and the cut-off point of LMR and PLR was chosen from its median. Logistic regression model was used to evaluate predictors of pNþ.
RESULTS 04-28.46, p [ 0.003) were independent predictors of pNþ. On multivariable logistic regression, adjusted for LMR, NLR, PLR, staging T, histological grade and lymphovascular invasion, the only ratio that remained statistically significant was LMR. When we stratified the LMR in 4 subgroups based on their values, we found the following percentages of pNþ (table 1) CONCLUSIONS: The current report identify NLR, PLR and LMR before ILND in PSCC as independent predictors of pathological nodal involvement. More studies are needed to confirm these findings.
